×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 4: TRANSPARENCY AND COMPLIANCE
Session Chair(s)
Janet Davies
Senior Director, Medical Information
Gilead Sciences, United Kingdom
Learning Objective : Participants should be able to distinguish the different kinds of transparency involved with the evaluation of medicines, to identify the issues at stake and to take part in the discussion between the different stakeholders
Speaker(s)
How Transparent are the Competent Authorities?
Diederick Slijkerman, PhD, LLM
Medicines Evaluation Board, Netherlands
Head of Policy, Governance & Regulatory Affairs
Affiliate Audit Findings and Learnings – the Medical Information Diaspora
Sangeetha Anand, PhD, MS
Vifor Pharma Group, Switzerland
Head Global Medical Information & Knowledge Management
Have an account?